MAPT and Alzheimer disease: Interestingly, both amyloid- and tau-expressing AD mouse models demonstrate ameliorated pathologies when components of the inflammasome are deleted [166,167], pointing to the importance of immune components and mediators in microglia (see Table 1 for a summary of microglia-specific receptors and signaling involvement during AD).